Click for best price
Lung Cancer Market Size, Share 2023
| Market size in 2022 |
US$ 20010 million
|
Forecast Market size by 2029 |
US$ 32920 million
|
| Growth Rate |
CAGR of 7.4% |
Number of Pages |
68 Pages |
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer. This report contains market size and forecasts of Lung Cancer in global, including the following market information:
Global Lung Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Lung Cancer market was valued at US$ 20010 million in 2022 and is projected to reach US$ 32920 million by 2029, at a CAGR of 7.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
We surveyed the Lung Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Lung Cancer Market Segment Percentages, by Type, 2022 (%)
Surgery
Chemotherapy
Radiotherapy
Photodynamic Therapy
Laser Therapy
Global Lung Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Lung Cancer Market Segment Percentages, by Application, 2022 (%)
Hospital & Clinics
Cancer Research Centers
Others
Global Lung Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Lung Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Lung Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer, market overview.
Chapter 2: Global Lung Cancer market size in revenue.
Chapter 3: Detailed analysis of Lung Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 20010 million
|
| Forecast Market size by 2029 |
US$ 32920 million
|
| Growth Rate |
CAGR of 7.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Overall Market Size
2.1 Global Lung Cancer Market Size: 2022 VS 2029
2.2 Global Lung Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Players in Global Market
3.2 Top Global Lung Cancer Companies Ranked by Revenue
3.3 Global Lung Cancer Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Market Size Markets, 2022 & 2029
4.1.2 Surgery
4.1.3 Chemotherapy
4.1.4 Radiotherapy
4.1.5 Photodynamic Therapy
4.1.6 Laser Therapy
4.2 By Type - Global Lung Cancer Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Revenue, 2024-2029
4.2.3 By Type - Global Lung Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Market Size, 2022 & 2029
5.1.2 Hospital & Clinics
5.1.3 Cancer Research Centers
5.1.4 Others
5.2 By Application - Global Lung Cancer Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Revenue, 2024-2029
5.2.3 By Application - Global Lung Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Lung Cancer Market Size, 2022 & 2029
6.2 By Region - Global Lung Cancer Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Revenue, 2024-2029
6.2.3 By Region - Global Lung Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Lung Cancer Revenue, 2018-2029
6.3.2 US Lung Cancer Market Size, 2018-2029
6.3.3 Canada Lung Cancer Market Size, 2018-2029
6.3.4 Mexico Lung Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Revenue, 2018-2029
6.4.2 Germany Lung Cancer Market Size, 2018-2029
6.4.3 France Lung Cancer Market Size, 2018-2029
6.4.4 U.K. Lung Cancer Market Size, 2018-2029
6.4.5 Italy Lung Cancer Market Size, 2018-2029
6.4.6 Russia Lung Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Lung Cancer Market Size, 2018-2029
6.4.8 Benelux Lung Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Revenue, 2018-2029
6.5.2 China Lung Cancer Market Size, 2018-2029
6.5.3 Japan Lung Cancer Market Size, 2018-2029
6.5.4 South Korea Lung Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Lung Cancer Market Size, 2018-2029
6.5.6 India Lung Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Lung Cancer Revenue, 2018-2029
6.6.2 Brazil Lung Cancer Market Size, 2018-2029
6.6.3 Argentina Lung Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Revenue, 2018-2029
6.7.2 Turkey Lung Cancer Market Size, 2018-2029
6.7.3 Israel Lung Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Lung Cancer Market Size, 2018-2029
6.7.5 UAE Lung Cancer Market Size, 2018-2029
7 Lung Cancer Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Lung Cancer Major Product Offerings
7.1.4 Roche Lung Cancer Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Lung Cancer Major Product Offerings
7.2.4 Novartis Lung Cancer Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Lung Cancer Major Product Offerings
7.3.4 Pfizer Lung Cancer Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Lung Cancer Major Product Offerings
7.4.4 Merck Lung Cancer Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Lung Cancer Major Product Offerings
7.5.4 Bristol-Myers Squibb Lung Cancer Revenue in Global Market (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 Eli Lilly And Company
7.6.1 Eli Lilly And Company Company Summary
7.6.2 Eli Lilly And Company Business Overview
7.6.3 Eli Lilly And Company Lung Cancer Major Product Offerings
7.6.4 Eli Lilly And Company Lung Cancer Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly And Company Key News & Latest Developments
7.7 Sanof
7.7.1 Sanof Company Summary
7.7.2 Sanof Business Overview
7.7.3 Sanof Lung Cancer Major Product Offerings
7.7.4 Sanof Lung Cancer Revenue in Global Market (2018-2023)
7.7.5 Sanof Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Market Drivers in Global Market
Table 3. Lung Cancer Market Restraints in Global Market
Table 4. Key Players of Lung Cancer in Global Market
Table 5. Top Lung Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lung Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lung Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lung Cancer Product Type
Table 9. List of Global Tier 1 Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lung Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lung Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Lung Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lung Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lung Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Lung Cancer Product Offerings
Table 32. Roche Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Lung Cancer Product Offerings
Table 36. Novartis Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Lung Cancer Product Offerings
Table 40. Pfizer Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Lung Cancer Product Offerings
Table 44. Merck Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Bristol-Myers Squibb Company Summary
Table 47. Bristol-Myers Squibb Lung Cancer Product Offerings
Table 48. Bristol-Myers Squibb Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Bristol-Myers Squibb Key News & Latest Developments
Table 50. Eli Lilly And Company Company Summary
Table 51. Eli Lilly And Company Lung Cancer Product Offerings
Table 52. Eli Lilly And Company Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly And Company Key News & Latest Developments
Table 54. Sanof Company Summary
Table 55. Sanof Lung Cancer Product Offerings
Table 56. Sanof Lung Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Sanof Key News & Latest Developments
List of Figures
Figure 1. Lung Cancer Segment by Type in 2022
Figure 2. Lung Cancer Segment by Application in 2022
Figure 3. Global Lung Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lung Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Revenue in 2022
Figure 8. By Type - Global Lung Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Lung Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Lung Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Lung Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Lung Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Lung Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Lung Cancer Revenue Market Share, 2018-2029
Figure 16. US Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Lung Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Lung Cancer Revenue Market Share, 2018-2029
Figure 28. China Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Lung Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Lung Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Lung Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly And Company Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanof Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
